Retroperitoneal fibrosis following treatment for Hodgkin's disease.

Published

Journal Article

With improvement and refinement of therapy, the majority of Hodgkin's disease patients are alive and free of disease at 5 years. As these patients continue to be observed, a variety of late complications have been reported. We describe herein three patients who developed retroperitoneal fibrosis following definitive therapy for Hodgkin's disease. The incidence approaches that seen with methysergide.

Full Text

Duke Authors

Cited Authors

  • Chao, N; Levine, J; Horning, SJ

Published Date

  • February 1, 1987

Published In

Volume / Issue

  • 5 / 2

Start / End Page

  • 231 - 232

PubMed ID

  • 3100728

Pubmed Central ID

  • 3100728

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/JCO.1987.5.2.231

Language

  • eng

Conference Location

  • United States